TY - JOUR
T1 - Papillomavirus capsid proteins mutually impact structure
AU - Chen, Horng Shen
AU - Conway, Michael J.
AU - Christensen, Neil D.
AU - Alam, Samina
AU - Meyers, Craig
N1 - Funding Information:
We thank Lynn Budgeon for histological expertise; and the members of the Meyers' laboratory for their critical reading of the manuscript and many helpful suggestions. This study was supported by a PHS grant from the National Institute of Allergy and Infectious Disease ( R01AI57988 ).
PY - 2011/4/10
Y1 - 2011/4/10
N2 - We studied a panel of mutant viruses containing wild-type and chimeric capsid HPV16 and HPV18 proteins. The mutant capsid protein expression, genome amplification, and episomal maintenance were comparable with the wild-type virus. However, the chimeric viruses varied in their titers from wild-type. We show that the intertypical mutant chimeric capsid viruses, that L2 affects the structure of L1 and that L1 affects the structure of L2 in the virion. These effects were measured using a panel of conformation-dependent neutralizing L1 MAbs and an L2 capsid surface peptide derived neutralizing antibody. These data suggest that variation of one capsid gene not only affects its own structure and antigenicity, but also affects the structure and antigenicity of the other capsid protein. Implications of our data suggest that for the continued effectiveness of a vaccine, variation in both capsid proteins need to be considered and not just the protein the vaccine is directed against.
AB - We studied a panel of mutant viruses containing wild-type and chimeric capsid HPV16 and HPV18 proteins. The mutant capsid protein expression, genome amplification, and episomal maintenance were comparable with the wild-type virus. However, the chimeric viruses varied in their titers from wild-type. We show that the intertypical mutant chimeric capsid viruses, that L2 affects the structure of L1 and that L1 affects the structure of L2 in the virion. These effects were measured using a panel of conformation-dependent neutralizing L1 MAbs and an L2 capsid surface peptide derived neutralizing antibody. These data suggest that variation of one capsid gene not only affects its own structure and antigenicity, but also affects the structure and antigenicity of the other capsid protein. Implications of our data suggest that for the continued effectiveness of a vaccine, variation in both capsid proteins need to be considered and not just the protein the vaccine is directed against.
UR - http://www.scopus.com/inward/record.url?scp=79952616842&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952616842&partnerID=8YFLogxK
U2 - 10.1016/j.virol.2011.01.018
DO - 10.1016/j.virol.2011.01.018
M3 - Article
C2 - 21329956
AN - SCOPUS:79952616842
SN - 0042-6822
VL - 412
SP - 378
EP - 383
JO - Virology
JF - Virology
IS - 2
ER -